the Fourth Hospital of Hebei Medical University
the Fourth Hospital of Hebei Medical University
Shijiazhuang, Hebei, China19 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Radiotherapy + Systemic Therapy as Conversion Therapy for pMMR/MSS T4M0 Colon Cancer（Neo-Color） | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, malignant colon neoplasm, neoplasm | Recruiting | Phase 2 | 2026-08-03 | NCT06949111 | |
| Becotatug Vedotin Plus Cisplatin and Radiotherapy in LA-ESCC | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, digestive system disorder, digestive system neoplasm, epithelial neoplasm, esophageal disorder, esophageal squamous cell carcinoma, neoplasm, squamous cell carcinoma, squamous cell neoplasm | Not yet recruiting | Phase 1 | 2026-07-10 | NCT07697040 | |
| Cardiac Safety Management and Immune Microenvironment Changes After Thoracic Radiotherapy: A Prospective Observational Study | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, heart disorder, pericardial effusion | Recruiting | Not stated | 2026-06-25 | NCT07669493 | |
| Pyrotinib Plus Trastuzumab and Chemotherapy for HER2-Positive Early Breast Cancer | HER2-positive Breast Cancer | Recruiting | Phase 2 | 2026-06-09 | NCT07635342 | |
| The CD19/CD20 Dual-Target in Vivo CAR-T Lentiviral Product in the Treatment of Relapsed/Refractory B-cell Malignancies | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence | Recruiting | Phase 1 | 2026-05-14 | NCT07002112 | |
| A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04] | Advanced Solid Tumour | Recruiting | Phase 2 | 2026-05-13 | NCT07390383 | |
| Neoadjuvant SHR-A1811 Combined With Pertuzumab in HER2-Positive Breast Cancer: An Exploratory Clinical Study. | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Not yet recruiting | Phase 2 | 2026-04-14 | NCT07528898 | |
| Dalpiciclib With or Without Entinostat and Letrozole in HR+/HER2- Early Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 2 | 2026-04-02 | NCT07492394 | |
| ctDNA Monitoring Guides the Treatment of NSCLC With Befotertinib Combined With Radiotherapy | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Not yet recruiting | Phase 2 | 2026-02-13 | NCT07410611 | |
| The Auxiliary Effect of Artificial Intelligence in the Detection of Precancerous Lesions in Proximal Colon Cancer | Abdominal Pain, Digestive System Diseases, Gastrointestinal Hemorrhage, Hemorrhage, Melena, Neurologic Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, constipation disorder, diarrheal disease, digestive system disorder | Not yet recruiting | Not stated | 2026-01-14 | NCT07338643 | |
| LIRRH Trial for the Right-sided Colon Cancer | ascending colon cancer | Recruiting | Not applicable | 2025-10-03 | NCT07207317 | |
| REmimazolam vs Propofol Total Intravenous Anesthesia on Outcomes After Major Noncardiac SurgEry | Anesthesia; Surgery-Complications | Recruiting | Phase 4 | 2025-08-26 | NCT05728775 | |
| A Phase II Clinical Study of Induction Adebrelimab Combined With Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC) | Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma | Not yet recruiting | Phase 2 | 2025-08-08 | NCT07112833 | |
| A Clinical Trial of TQB2102 for Injection in Gynecological Tumors With Recurrent/Metastatic Advanced | Gynecological Tumors | Recruiting | Phase 2 | 2025-07-18 | NCT06798207 | |
| Liposomal Irinotecan and Leucovorin/5-fluorouracil Plus Bevacizumab in Metastatic Colorectal Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Recruiting | Phase 2 | 2024-10-09 | NCT06184698 | |
| Comparative Effectiveness of Intervention in Multi-level Hospitals for Acute Traumatic Brain Injury(Metric-TBI) | Brain Injuries, Traumatic, Craniocerebral Trauma, brain disorder, brain injury, central nervous system disorder, injury, nervous system disorder, nervous system injury | Recruiting | Not stated | 2024-09-04 | NCT06429774 | |
| A Trial of SHR-A1811 Combined With Other Antitumor Therapies in Advanced Solid Tumors. | HER2-expressing Advanced Solid Tumors | Recruiting | Phase 1 / Phase 2 | 2024-08-05 | NCT06015048 | |
| The Efficacy and Safety of Pyrotinib, Trastuzumab Combined With Taxanes in the Treatment of Trastuzumab-treated HER2+ Advanced Breast Cancer (ABC). | Advanced Breast Cancer; HER2-positive Breast Cancer | Recruiting | Phase 4 | 2024-02-28 | NCT06217185 | |
| YK-029A as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Not yet recruiting | Phase 3 | 2023-04-05 | NCT05767892 |